A comprehensive clinicopathological analysis revealed that gastric cancer patients lacking DNA-PKcs expression exhibited significantly worse survival outcomes compared to those with preserved expression (p = 0.004) [135]. The gene discussed is PRKDC; the disease is gastric cancer.